Published 5 days ago • loading... • Updated 4 days ago

Varied Access: The Pharmacogenetic Testing Coverage Divide

Summary by ajmc.com

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

redaccionmedica.com

HUCA creates its Pharmacogenetics Unit to adapt therapies to the patient

The Hospital Universitario Central de Asturias (HUCA) has launched a Pharmacogenetics Unit to improve the safety and efficacy of treatments through the application of individualized genetic studies, which is known as precision personalized medicine. This new area will allow adapting therapies to the genetics of each patient, so that adverse effects are reduced and the response to treatments is optimized. This discipline analyzes how the genetic …

4 days ago

Read Full Article